Stockscreener 앱 받기
97.71
1.03%
-1.02
전일 마감가:
$98.73
열려 있는:
$98.42
하루 거래량:
210.86K
Relative Volume:
0.47
시가총액:
$2.12B
수익:
$486.82M
순이익/손실:
$18.78M
주가수익비율:
119.16
EPS:
0.82
순현금흐름:
$100.45M
1주 성능:
+2.48%
1개월 성능:
+10.61%
6개월 성능:
+54.46%
1년 성능:
+74.02%
1일 변동 폭
$97.18
$99.10
1주일 범위
$94.31
$99.50
52주 변동 폭
$52.50
$99.50
Ani Pharmaceuticals Inc Stock (ANIP) Company Profile
명칭
Ani Pharmaceuticals Inc
전화
(218) 634-3500
주소
210 MAIN STREET WEST, BAUDETTE, MN
ANIP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ANIP
Ani Pharmaceuticals Inc
|
97.71 | 2.11B | 486.82M | 18.78M | 100.45M | 0.82 |
|
ZTS
Zoetis Inc
|
148.20 | 66.22B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.10 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.81 | 43.99B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.93 | 22.45B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
405.02 | 17.93B | 2.99B | 1.21B | 1.13B | 25.06 |
Ani Pharmaceuticals Inc Stock (ANIP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-10 | 개시 | H.C. Wainwright | Buy |
| 2025-03-14 | 개시 | Jefferies | Buy |
| 2025-03-12 | 개시 | JP Morgan | Overweight |
| 2024-12-11 | 개시 | Leerink Partners | Outperform |
| 2024-10-11 | 개시 | Piper Sandler | Overweight |
| 2024-03-15 | 개시 | CapitalOne | Overweight |
| 2023-08-22 | 재확인 | H.C. Wainwright | Buy |
| 2023-03-01 | 개시 | Guggenheim | Buy |
| 2022-09-07 | 개시 | H.C. Wainwright | Buy |
| 2021-11-02 | 개시 | Truist | Buy |
| 2020-05-07 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2019-09-12 | 개시 | Guggenheim | Buy |
| 2019-05-10 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2017-10-16 | 재확인 | Canaccord Genuity | Buy |
| 2017-07-31 | 개시 | Canaccord Genuity | Buy |
| 2017-02-22 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2016-06-23 | 개시 | Raymond James | Strong Buy |
| 2016-05-24 | 다운그레이드 | Standpoint Research | Buy → Hold |
| 2015-11-13 | 개시 | Standpoint Research | Buy |
| 2015-09-28 | 업그레이드 | ROTH Capital | Neutral → Buy |
| 2015-08-05 | 재확인 | Oppenheimer | Outperform |
| 2015-08-04 | 재확인 | ROTH Capital | Neutral |
| 2015-07-31 | 재확인 | Oppenheimer | Outperform |
| 2015-07-15 | 재확인 | ROTH Capital | Neutral |
| 2015-06-23 | 재확인 | Oppenheimer | Outperform |
| 2015-05-18 | 재확인 | ROTH Capital | Neutral |
| 2015-05-06 | 재확인 | Oppenheimer | Outperform |
| 2015-04-10 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2015-02-26 | 재확인 | ROTH Capital | Buy |
| 2015-02-18 | 재확인 | Oppenheimer | Outperform |
모두보기
Ani Pharmaceuticals Inc 주식(ANIP)의 최신 뉴스
Comerica Bank Sells 7,280 Shares of ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals, Inc. $ANIP Shares Purchased by Federation des caisses Desjardins du Quebec - MarketBeat
Millennium Management LLC Lowers Stock Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals, Inc. $ANIP Shares Sold by Great Lakes Advisors LLC - MarketBeat
Parkman Healthcare Partners LLC Purchases New Stake in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals (NASDAQ:ANIP) Sets New 1-Year High on Analyst Upgrade - MarketBeat
ANI Pharmaceuticals (NASDAQ:ANIP) Price Target Raised to $114.00 at Guggenheim - MarketBeat
ANI Pharmaceuticals, Inc. $ANIP Shares Acquired by Northern Trust Corp - MarketBeat
Transcript : ANI Pharmaceuticals, Inc. Presents at Morgan Stanley 23rd Annual Global Healthcare Conference, Sep-09-2025 01 - MarketScreener
Is ANI Pharmaceuticals Inc. stock a hidden gemQuarterly Earnings Report & High Conviction Trade Alerts - Lancaster City Council
Ani Pharmaceuticals stock hits 52-week high at 96.61 USD - Investing.com
Is ANI Pharmaceuticals Inc. forming higher highs and higher lowsQuarterly Growth Report & Fast Exit and Entry Strategy Plans - Lancaster City Council
Ani Pharmaceuticals stock hits 52-week high at 96.61 USD By Investing.com - Investing.com Nigeria
ANI Pharmaceuticals, Inc. (ANIP) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
ANI Pharmaceuticals at H.C. Wainwright: Driving Growth in Rare Diseases By Investing.com - Investing.com Canada
Earnings Chart Overlay Points to ANI Pharmaceuticals Inc. UpsideJuly 2025 Levels & Free High Return Stock Watch Alerts - beatles.ru
AYAL Capital Advisors Ltd Buys New Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals (NASDAQ:ANIP) Reaches New 1-Year HighWhat's Next? - MarketBeat
Can machine learning forecast ANI Pharmaceuticals Inc. recovery2025 Sector Review & Stock Portfolio Risk Control - Newser
Is ANI Pharmaceuticals Inc. a cyclical or defensive stockJuly 2025 Retail & Weekly Hot Stock Watchlists - خودرو بانک
Is ANI Pharmaceuticals Inc. forming a bottoming baseWeekly Volume Report & Real-Time Volume Analysis Alerts - Newser
8,206 Shares in ANI Pharmaceuticals, Inc. $ANIP Bought by Wellington Management Group LLP - MarketBeat
Published on: 2025-09-05 23:12:27 - خودرو بانک
Is ANI Pharmaceuticals Inc. a strong growth stock2025 Market Sentiment & Smart Investment Allocation Insights - خودرو بانک
What to do if you’re stuck in ANI Pharmaceuticals Inc.July 2025 Gainers & Precise Buy Zone Identification - Newser
Should I set a stop loss on ANI Pharmaceuticals Inc.2025 AllTime Highs & Long-Term Capital Growth Ideas - خودرو بانک
What data driven models say about ANI Pharmaceuticals Inc.’s future - Newser
Is ANI Pharmaceuticals Inc.’s growth already priced in2025 Earnings Impact & Advanced Swing Trade Entry Plans - خودرو بانک
Apis Capital Advisors LLC Makes New $4.35 Million Investment in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
What is ANI Pharmaceuticals Inc.’s book value per share2025 Market WrapUp & Safe Entry Trade Reports - خودرو بانک
ANI Pharmaceuticals Inc. stock outlook for YEAR2025 Technical Overview & Free Risk Controlled Daily Trade Plans - Newser
Forecasting ANI Pharmaceuticals Inc. price range with options dataWeekly Gains Summary & Growth Oriented Trading Recommendations - Newser
What Fibonacci levels say about ANI Pharmaceuticals Inc. reboundQuarterly Portfolio Report & Free Community Supported Trade Ideas - Newser
Technical signs of recovery in ANI Pharmaceuticals Inc.July 2025 Movers & Daily Oversold Bounce Ideas - Newser
How to monitor ANI Pharmaceuticals Inc. with trend dashboardsMarket Volume Report & Risk Adjusted Swing Trade Ideas - Newser
Leading vs lagging indicators on ANI Pharmaceuticals Inc. performanceMarket Performance Recap & Reliable Price Breakout Alerts - Newser
What technical models suggest about ANI Pharmaceuticals Inc.’s comebackJobs Report & Community Consensus Trade Signals - Newser
Fed Meeting: Is ANI Pharmaceuticals Inc. stock forming a cup and handleCEO Change & Safe Entry Trade Signal Reports - خودرو بانک
Should you hold or exit ANI Pharmaceuticals Inc. nowWall Street Watch & Verified Momentum Stock Watchlist - Newser
Aug Swings: Is ANI Pharmaceuticals Inc.’s growth already priced inLayoff News & Weekly Market Pulse Alerts - خودرو بانک
What machine learning models say about ANI Pharmaceuticals Inc.Portfolio Return Report & Free Reliable Trade Execution Plans - Newser
Using R and stats models for ANI Pharmaceuticals Inc. forecasting2025 Support & Resistance & Safe Entry Zone Tips - Newser
Can trapped investors hope for a rebound in ANI Pharmaceuticals Inc.Market Sentiment Review & Growth Focused Stock Pick Reports - Newser
Walleye Capital LLC Has $2.09 Million Stock Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Ani Pharmaceuticals shares rise 1.98% after-hours following CG Oncology's PIVOT-006 study enrollment completion. - AInvest
Is this a good reentry point in ANI Pharmaceuticals Inc.Portfolio Risk Report & Weekly High Potential Stock Alerts - Newser
Sector ETF performance correlation with ANI Pharmaceuticals Inc.Weekly Loss Report & Free Real-Time Market Sentiment Alerts - Newser
Nuveen LLC Takes Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Best data tools to analyze ANI Pharmaceuticals Inc. stock2025 Trade Ideas & AI Based Buy/Sell Signal Reports - Newser
Is ANI Pharmaceuticals Inc. stock good for income investorsTrade Analysis Summary & Daily Profit Maximizing Trade Tips - خودرو بانک
Published on: 2025-09-02 23:11:03 - Newser
Ani Pharmaceuticals Inc (ANIP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.67%
0.04%
자본화:
|
볼륨(24시간):